Bavarian Nordic — November 2019
-
-
Tak trods alt @ pensionist. Sjovt nok, at man sætter en så stor del af en virksomhed i spil, uden at man rigtig kan læse om konsekvenserne nogen steder. Måske forandrer det sig efter generalforsamlingen. En konkret plan og konsekvensanalyse er da ret vigtig for os aktionærer.
-
1
-
-
Ebola vaccine approved in Europe in landmark moment in fight against a deadly disease
The European Commission granted marketing authorization to Merck’s vaccine, giving the world for the first time an approved vaccine against Ebola.
STAT (www.statnews.com)
-
Rigtig
fin nyhed: BAVA tager vaccine-salgs-topmanden fra GSK - Jean-Christophe May, Global Vaccines Commercialization Leader - samtidigt med vaccinerne. Han må være en af dem, der ved mest om vaccinerne og hvordan man bør gribe (intensiveret) markedsføring an. -
News | Bavarian Nordic
Bavarian Nordic - a pioneering force in vaccines – expanding our reach and impact through life-changing solutions
(www.bavarian-nordic.com)
-
Blot en lille servicemeddelse om at man kan møde Bavarian ved selvsyn d. 21. november og stille spørgsmål. https://www.eventbrite.co.uk/e/kapitalmarkedseftermiddag-2111-2019-nu-med-astralis-ogsa-tickets-79684958857
-
Podcast med Zealand: https://www.proinvestor.com/index.php?p=debat_1&postid=79181
-
-
Zealand Pharma completes Phase 3 clinical program for HypoPal
rescue pen, initiates a new Phase 2 clinical proof of concept trial with dasiglucagon, and secures DKK 560 million in additional investment
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind